NovaLux announces pursuit of dual appeal

NovaLux, a vertical license applicant in the Kansas City area, announced this weekend that they had elected to pursue the appeals process in regards to the denial of their facility licenses.

NovaLux CEO John Blosser noted in his open letter that the company had filed a dual appeal, a first of its kind to this point.

NovaLux Healthcare Holdings, Inc. is pleased to announce that our dual appeal (Cultivation Facility and Manufacturing Facility) has been successfully submitted and accepted by the Administrative Hearing Commission as of 3:38pm on Friday. To our knowledge, this is the 1st dual license appeal within the State of Missouri and the 19th appeal overall. We fully expect to resolve all licensure issues prior to our planned operational launch on or about June 1. In the meantime, we are planning, designing, and building out our organization and facilities, according to our original schedule, with the intent of fully recognizing our vision of curating and dispensing the diamond standard for medical cannabis in the State of Missouri. We would like to thank our legal team, strategic collaborators, and the patients of Missouri for your continuing support and confidence in our organization.